Filing Details

Accession Number:
0000905148-25-001597
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-13 16:48:13
Reporting Period:
2025-05-09
Filing Date:
2025-05-13
Accepted Time:
2025-05-13 16:48:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1731790 Ying Du C/O Zai Lab Limited
314 Main Street, 4Th Floor, Suite 100
Cambridge MA 02142
Chairperson & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Acquisiton 2025-05-09 50,000 $0.60 529,851 No 4 M Direct
American Depositary Shares Disposition 2025-05-09 46,362 $29.58 483,489 No 4 S Direct
American Depositary Shares Disposition 2025-05-09 3,638 $30.16 479,851 No 4 S Direct
American Depositary Shares Acquisiton 2025-05-12 50,000 $0.60 529,851 No 4 M Direct
American Depositary Shares Disposition 2025-05-12 49,384 $29.44 480,467 No 4 S Direct
American Depositary Shares Disposition 2025-05-12 616 $29.92 479,851 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
American Depositary Shares Stock Options (Right to Buy) Disposition 2025-05-09 50,000 $0.00 50,000 $0.60
American Depositary Shares Stock Options (Right to Buy) Disposition 2025-05-12 50,000 $0.00 50,000 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
342,776 2025-10-22 No 4 M Direct
292,776 2025-10-22 No 4 M Direct
Footnotes
  1. Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
  2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.
  3. Reflects a weighted average sale price of $29.5803 per share, at prices ranging from $29.125 to $30.12 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  4. Reflects a weighted average sale price of $30.1645 per share, at prices ranging from $30.125 to $30.24 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. Reflects a weighted average sale price of $29.4374 per share, at prices ranging from $28.89 to $29.88 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  6. Reflects a weighted average sale price of $29.9201 per share, at prices ranging from $29.91 to $30.00 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  7. The Stock Options fully vested as of October 22, 2020.